Parabilis Medicines, Inc. Operating Expenses
Parabilis Medicines, Inc. (PBLS) reported Operating Expenses of $51.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- Parabilis Medicines, Inc. operating expenses for the quarter ending 2026-06-30 was $51.03M, a 39.74% increase year-over-year.
- Parabilis Medicines, Inc. operating expenses for the quarter ending 2025-06-30 was $36.52M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month |
|---|---|---|
| 2026-06-30 | $51.03M 10-Q · filed 2026-08-13 | $98.49M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $36.52M 10-Q · filed 2026-08-13 | $76.76M 10-Q · filed 2026-08-13 |